Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression

Background Autosomal dominant polycystic kidney disease (ADPKD), one of the most common human monogenic diseases, is characterized by the presence of numerous fluid-filled renal cysts and is a leading cause of end-stage renal disease (ESRD). Urinary biomarkers may be useful for predicting the variab...

Full description

Bibliographic Details
Published in:	Kidney Research and Clinical Practice
Main Authors:	Hyunsuk Kim, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, Hyunho Kim
Format:	Article
Language:	English
Published:	The Korean Society of Nephrology 2022-11-01
Subjects:	autosomal dominant polycystic kidney disease biomarkers clustered regularly interspaced short palindromic repeats/cas9 osteopontin
Online Access:	http://www.krcp-ksn.org/upload/pdf/j-krcp-21-303.pdf

Similar Items

CRISPR-Cas9 system in autosomal dominant polycystic kidney disease: a comprehensive review
by: Seungyeon Kang, et al.
Published: (2025-02-01)

Is ignorance bliss? Milk from gene-edited cows and animal welfare considerations
by: Jill J. McCluskey, et al.

AUTOSOMAL – DOMINANT POLYCYSTIC KIDNEY DISEASE – A GLEAM OF HOPE?
by: V.V. Doretskyi, et al.
Published: (2014-01-01)

Femoral Neuropathy Secondary to Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Jeehyun Yoo, et al.
Published: (2018-06-01)

CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
by: Sasan Ghaffari, et al.
Published: (2021-08-01)

Intracranial aneurysms in autosomal dominant polycystic kidney disease
by: Jung Hyun Park
Published: (2024-12-01)

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
by: Matt Gittus, et al.
Published: (2025-02-01)

Effectiveness of abdominal bracing core exercises as rehabilitation therapy for reducing abdominal symptoms in patients with autosomal dominant polycystic kidney disease and significant polycystic liver disease
by: Jaeyeong Yoo, et al.
Published: (2025-12-01)

Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
by: Hee Sun Beak, et al.
Published: (2023-12-01)

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
by: Yaerim Kim, et al.
Published: (2023-05-01)

Endovascular Management of Renal Artery Pseudoaneurysm in Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Garima Sharma, et al.
Published: (2024-10-01)

Application of engineered CRISPR/Cas12a variants with altered protospacer adjacent motif specificities for the detection of isoniazid resistance mutations in Mycobacterium tuberculosis
by: Peng Liu, et al.
Published: (2025-10-01)

Genomic investigation of emerging zoonotic pathogen Shewanella xiamenensis
by: Jui-Hsing Wang, et al.
Published: (2020-01-01)

Update on the Application of Ultrasonography in Understanding Autosomal Dominant Polycystic Kidney Disease
by: Wen-Chin Lee, et al.
Published: (2024-04-01)

LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
by: O. N. Reznik, et al.
Published: (2016-11-01)

Are you ready to accompany autosomal dominant polycystic kidney disease patients in their treatment journey? Real practice for selecting rapid progressors and treatment with tolvaptan
by: Yeonsoon Jung, et al.
Published: (2023-06-01)

Gene therapy in hereditary retinal dystrophy
by: Jia-Ying Chien, et al.
Published: (2022-01-01)

Inconsistent treatments of the kinetics of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) impair assessment of its diagnostic potential
by: Juan G. Santiago
Published: (2022-01-01)

Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing
by: Neda Rostami, et al.
Published: (2024-10-01)

Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?
by: Stéphanie De Rechter, et al.
Published: (2017-12-01)

Results of kidney transplantation in patients with end-stage renal failure caused by autosomal dominant polycystic kidney disease
by: V. S. Daineko, et al.
Published: (2019-07-01)

Polycystic Kidney Disease–Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative StudyPlain-Language Summary
by: Dorothee Oberdhan, et al.
Published: (2022-03-01)

The Effect of Autosomal Dominant Polycystic Kidney Disease on Spirometric Parameters
by: Tuba Elif Özler, et al.
Published: (2020-10-01)

Plasma Copeptin Levels in Autosomal Dominant Polycystic Kidney Disease
by: Vaishnavi Venkatasubramanian, et al.
Published: (2025-01-01)

Mortality risk in patients with autosomal dominant polycystic kidney disease
by: Deirdre Mladsi, et al.
Published: (2024-02-01)

Differences in gut microbiome between autosomal dominant polycystic kidney disease with and without intracranial aneurysms
by: Tatsumaru Fukuda, et al.
Published: (2025-07-01)

Therapeutic Effect of Somatostatin Analogue to Slow Disease Progression in Autosomal Dominant Polycystic Kidney Disease
by: Irvin Rembrant Holleritz Sitompul, et al.
Published: (2024-12-01)

Frequency of Nerve Root Sleeve Cysts in Autosomal Dominant Polycystic Kidney Disease
by: Murat Aşık, et al.
Published: (2016-12-01)

Recent Advances in CRISPR/Cas System-Based Biosensors for the Detection of Foodborne Pathogenic Microorganisms
by: Sanlei Xie, et al.
Published: (2024-10-01)

The I510V mutation in KLHL10 in a patient with oligoasthenoteratozoospermia
by: Zicong HUANG, et al.
Published: (2021-08-01)

Clinical manifestations, imaging findings and laboratory abnormalities in 51 patients with autosomal dominant polycystic kidney disease: Experience at Tirupati, South India
by: K M Bhargav, et al.
Published: (2018-01-01)

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
by: Hyuk Huh, et al.
Published: (2023-03-01)

Detection and Distribution of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) in Campylobacter jejuni Isolates from Chicken Livers
by: Hung-Yueh Yeh, et al.
Published: (2024-04-01)

CRISPR‐based environmental DNA detection for a rare endangered estuarine species
by: Raman P. Nagarajan, et al.
Published: (2024-01-01)

Effects of SNX9 on the structure and function of primary cilia in autosomal dominant polycystic kidney disease
by: Shen Ai-wen, et al.
Published: (2021-01-01)

Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic kidney: a case report
by: Yaw Amoah, et al.
Published: (2024-01-01)

Cardiac Involvement in Autosomal Dominant Polycystic Kidney Disease
by: Letizia Spinelli, et al.
Published: (2021-04-01)

Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review
by: Maria Pietrzak-Nowacka, et al.
Published: (2023-12-01)

The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease—A Primer for Clinicians
by: Adrián Cordido, et al.
Published: (2017-12-01)

Leucine-rich α-2-glycoprotein 1 can be a novel angiogenic mediator in autosomal dominant polycystic kidney disease
by: Erdogan Hazal Fatma, et al.
Published: (2025-03-01)